Axoft Secures $55M for Implantable Brain-Computer Interfaces
Summary
Axoft secures $55M to scale its bio-inspired, soft iBCI platform. Fleuron™ material is redefining neural data capture global clinical trials.
Description
Axoft secures $55M to scale its bio-inspired, soft iBCI platform. Fleuron™ material is redefining neural data capture global clinical trials.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source